CytoMed Therapeutics

GDTC · NASDAQ

$0.919+$0.00 (+0.00%)TodayMarket closed ·
Prev close $0.919

Who owns GDTC

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 69.9% of GDTC’s shares.

  • Glorious Finance Limited31.6%
  • mDR Limited10.2%
  • Wang (Shu)7.4%
  • 28 Consultants Ltd7.4%
  • Next 6 largest institutions13.2%
  • All other shareholders30.1%
Top institutional holders of GDTC
HolderShares% of shares
Glorious Finance Limited3.77M31.63%
mDR Limited1.22M10.24%
Wang (Shu)883.86K7.41%
28 Consultants Ltd880.31K7.38%
Choo (Chee Kong)824.44K6.91%
Jieming (Zeng)589.24K4.94%
Luk (Lucas Tien Wee)103.81K0.87%
Tan (Yoong Ying)25.78K0.22%
Goh (Yvonne)25.78K0.22%
Axiom Investment Management, LLC7.03K0.06%

Largest mutual fund holders

Top mutual fund holders of GDTC
HolderShares% of shares
Fidelity NASDAQ Composite Index Fund4.85K0.04%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders bought $728.78K (5 trades) of GDTC on the open market, with no sales.

Latest GDTC insider transactions
InsiderTypeSharesValue
Choo Chee KongBuy100.00K$150.00K
Choo Chee KongBuy100.00K$150.00K
Choo Chee KongBuy100.00K$150.00K
Choo Chee KongBuy100.00K$150.00K
Choo Chee KongBuy112.00K$128.78K

Short interest

Settled Sep 30, 2026

Shares short
17.10K
Days to cover
1.07
% of shares outstanding
0.14%
Average daily volume
15.99K
Change since last report
+372.4%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.